Production System
Jiuzhitang Maker has established a large-scale stem cell R&D and manufacturing facility in China Pharma Valley, compliant with China’s NMPA, the EU’s EMA, and the U.S. FDA GMP standards. The facility boasts an office and production area of approximately 4,800㎡, featuring four independent B+A clean zones on its production platform—enabling the manufacture of clinical-grade stem cells that meet both Chinese and U.S. regulatory requirements for drug submissions.
Special low-oxygen production process
Jiuzhitang Maker's unique hypoxic production process mimics the body's natural microenvironment, resulting in stem cells that exhibit enhanced homing ability, proliferative capacity, tissue-repair potential, ischemia tolerance, and improved inflammation-regulating properties.
Efficient large-scale production technology
Jiuzhitang Maker has introduced stem cell technology from the U.S.-based Stemedica Cell Technologies, further upgrading and refining its production processes and quality systems. This move addresses critical bottlenecks in the standardized production and large-scale manufacturing of stem cells, ensuring stable cell quality while enabling scalable, mass production.
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy